Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4050
MAIA
MAIA Biotechnology, Inc. Common Stock
1.32 USD-5.04%-2.94%+10.92%-36.54%80.29 M USD
4055
TENX
Tenax Therapeutics, Inc. - Common Stock
2.13 USD-2.74%+25.29%-85.70%-71.79%79.71 M USD
4071
CING
Cingulate Inc. - Common Stock
5.33 USD-2.02%-3.27%+17.66%-13.47%77.51 M USD
4072
GANX
Gain Therapeutics, Inc. - Common Stock
1.77 USD-4.32%-11.94%+4.12%-7.81%77.25 M USD

Frequently asked questions about Telomir Pharmaceuticals, Inc. Common Stock

What is the Telomir Pharmaceuticals, Inc. Common Stock stock price today?

The current price of Telomir Pharmaceuticals, Inc. Common Stock (TELO) is 1.14. Over the past 24 hours, the stock has changed by -4.20%. Follow the TELO chart for real-time price dynamics.

What is the stock ticker of Telomir Pharmaceuticals, Inc. Common Stock?

Telomir Pharmaceuticals, Inc. Common Stock trades under the ticker TELO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Telomir Pharmaceuticals, Inc. Common Stock stock going up?

TELO has changed by +0.88% over the last week, -6.56% over the last month, and -12.31% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Telomir Pharmaceuticals, Inc. Common Stock?

Telomir Pharmaceuticals, Inc. Common Stock currently has a market capitalization of 78.4 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Telomir Pharmaceuticals, Inc. Common Stock earnings last quarter?

Last quarter, Telomir Pharmaceuticals, Inc. Common Stock reported earnings of -0.79 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Telomir Pharmaceuticals, Inc. Common Stock revenue for the last quarter?

Telomir Pharmaceuticals, Inc. Common Stock reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Telomir Pharmaceuticals, Inc. Common Stock net income for the last quarter?

Telomir Pharmaceuticals, Inc. Common Stock reported net income of -1.72 M for the last quarter. The previous quarter showed -990.95 K, which means net income changed by -73.73%.

How many employees does Telomir Pharmaceuticals, Inc. Common Stock have?

As of the latest available data, Telomir Pharmaceuticals, Inc. Common Stock has 5 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Telomir Pharmaceuticals, Inc. Common Stock stock?

You can buy Telomir Pharmaceuticals, Inc. Common Stock (TELO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Telomir Pharmaceuticals, Inc. Common Stock stock?

Investing in Telomir Pharmaceuticals, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TELO chart and related analysis on metatrader.com as part of your research.

News